Intelligent surgical targeting

September 21, 2020

Press release

FluoGuide appoints Henrik Moltke as Chief Financial Officer

Copenhagen, 21 September 2020 – FluoGuide A/S (“FluoGuide” or “the Company”)... [Read more]

September 3, 2020

Press release

FluoGuide announces regulatory approval from Danish Medicines Agency to commence Phase I/II clinical trial with FG001 in guiding surgery of high grade glioma (including glioblastoma)

Copenhagen, Denmark, 3 September 2020 – FluoGuide A/S (“FluoGuide” or “the... [Read more]

August 14, 2020

Press release

FluoGuide A/S interim report for the period January – June 2020

Copenhagen, Denmark, 14 August 2020 – FluoGuide A/S (“FluoGuide” or “the... [Read more]

August 13, 2020

Press release

FluoGuide A/S and LI-COR Biosciences sign agreement to develop uPAR targeted products to guide oncology surgery using LI-COR’s proprietary next-generation fluorophore IRDye 800CW

Copenhagen, Denmark, 13 August 2020 – FluoGuide A/S (“FluoGuide” or “the... [Read more]